Android app Apple app link

TransMedics Group, Inc. (TMDX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$143.37

$0.32 (-0.22%)
Last update: 01:17 PM EST
Day's range
$140.41
Day's range
$149.22

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/30/2025 Piper Sandler Matt O'Brien $140.00 $134.32   4.23%
10/30/2025 Canaccord Genuity Jason Mills $147.00 $134.32   9.44%
12/11/2024 Robert W. Baird David Rescott $120.00 $67.36   78.15%
12/11/2024 Piper Sandler Matt O'Brien $90.00 $67.36   33.61%
10/29/2024 Robert W. Baird Joe Vruwink $150.00 $88.70   69.11%
10/29/2024 Canaccord Genuity Jason Mills $109.00 $126.24   -13.66%
10/29/2024 Needham Mike Matson $109.00 $126.24   -13.66%
10/29/2024 Oppenheimer Suraj Kalia $125.00 $126.24   -0.98%
09/23/2024 Robert W. Baird David Rescott $200.00 $159.50   25.39%
09/04/2024 Piper Sandler Matt O'Brien $180.00 $158.42   13.62%
08/21/2024 Needham Mike Matson $208.00 $166.18   25.17%
08/01/2024 Canaccord Genuity William Plovanic $169.00 $164.02   3.04%
08/01/2024 Oppenheimer Suraj Kalia $200.00 $142.26   40.59%
07/15/2024 Morgan Stanley Patrick Wood $145.00 $142.19   1.98%
07/15/2024 Piper Sandler Matt O'Brien $170.00 $142.19   19.56%
06/03/2024 Stephens George Sellers $151.00 $133.63   13%

TransMedics Group, Inc. FAQ's

TransMedics Group, Inc. has been rated by research analysts at Canaccord Genuity, Needham, Morgan Stanley, Piper Sandler, Jefferies, Evercore ISI in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.